vs

Side-by-side financial comparison of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and HEALTHY CHOICE WELLNESS CORP. (HCWC). Click either name above to swap in a different company.

ASCENTAGE PHARMA GROUP INTERNATIONAL is the larger business by last-quarter revenue ($32.6M vs $18.7M, roughly 1.7× HEALTHY CHOICE WELLNESS CORP.).

Ascentage Pharma Group International is a global clinical-stage biotechnology company specializing in developing novel targeted therapies for cancers, chronic viral infections, and age-related diseases. It focuses on small molecule drugs targeting apoptosis pathways and other key oncogenic mechanisms, with operations spanning China, the U.S., and other global markets, serving patients with unmet medical needs worldwide.

AAPG vs HCWC — Head-to-Head

Bigger by revenue
AAPG
AAPG
1.7× larger
AAPG
$32.6M
$18.7M
HCWC

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
AAPG
AAPG
HCWC
HCWC
Revenue
$32.6M
$18.7M
Net Profit
$11.4M
$-1.7M
Gross Margin
90.7%
39.1%
Operating Margin
-7.6%
Net Margin
-8.9%
Revenue YoY
Net Profit YoY
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAPG
AAPG
HCWC
HCWC
Q4 25
$18.7M
Q3 25
$19.0M
Q2 25
$32.6M
$20.2M
Q1 25
$20.3M
Q3 24
$18.2M
Net Profit
AAPG
AAPG
HCWC
HCWC
Q4 25
$-1.7M
Q3 25
$-1.2M
Q2 25
$11.4M
$-339.4K
Q1 25
$-712.4K
Q3 24
$-2.7M
Gross Margin
AAPG
AAPG
HCWC
HCWC
Q4 25
39.1%
Q3 25
38.8%
Q2 25
90.7%
40.1%
Q1 25
38.8%
Q3 24
38.4%
Operating Margin
AAPG
AAPG
HCWC
HCWC
Q4 25
-7.6%
Q3 25
-3.2%
Q2 25
-0.2%
Q1 25
-2.0%
Q3 24
-2.0%
Net Margin
AAPG
AAPG
HCWC
HCWC
Q4 25
-8.9%
Q3 25
-6.4%
Q2 25
-1.7%
Q1 25
-3.5%
Q3 24
-14.6%
EPS (diluted)
AAPG
AAPG
HCWC
HCWC
Q4 25
$-0.05
Q3 25
$-0.09
Q2 25
$-0.03
Q1 25
$-0.07
Q3 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAPG
AAPG
HCWC
HCWC
Cash + ST InvestmentsLiquidity on hand
$3.0M
Total DebtLower is stronger
$7.3M
Stockholders' EquityBook value
$7.3M
Total Assets
$33.5M
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAPG
AAPG
HCWC
HCWC
Q4 25
$3.0M
Q3 25
$3.0M
Q2 25
$4.7M
Q1 25
$1.8M
Q3 24
$1.8M
Total Debt
AAPG
AAPG
HCWC
HCWC
Q4 25
$7.3M
Q3 25
$8.5M
Q2 25
$9.7M
Q1 25
$10.6M
Q3 24
$11.6M
Stockholders' Equity
AAPG
AAPG
HCWC
HCWC
Q4 25
$7.3M
Q3 25
$5.9M
Q2 25
$5.8M
Q1 25
$2.1M
Q3 24
$2.9M
Total Assets
AAPG
AAPG
HCWC
HCWC
Q4 25
$33.5M
Q3 25
$33.7M
Q2 25
$36.4M
Q1 25
$34.1M
Q3 24
$33.2M
Debt / Equity
AAPG
AAPG
HCWC
HCWC
Q4 25
1.00×
Q3 25
1.43×
Q2 25
1.69×
Q1 25
5.01×
Q3 24
3.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAPG
AAPG
HCWC
HCWC
Operating Cash FlowLast quarter
$-855.1K
Free Cash FlowOCF − Capex
$-927.1K
FCF MarginFCF / Revenue
-5.0%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$675.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAPG
AAPG
HCWC
HCWC
Q4 25
$-855.1K
Q3 25
$-308.7K
Q2 25
$1.1M
Q1 25
$1.1M
Q3 24
Free Cash Flow
AAPG
AAPG
HCWC
HCWC
Q4 25
$-927.1K
Q3 25
$-351.3K
Q2 25
$988.6K
Q1 25
$965.3K
Q3 24
FCF Margin
AAPG
AAPG
HCWC
HCWC
Q4 25
-5.0%
Q3 25
-1.8%
Q2 25
4.9%
Q1 25
4.8%
Q3 24
Capex Intensity
AAPG
AAPG
HCWC
HCWC
Q4 25
0.4%
Q3 25
0.2%
Q2 25
0.4%
Q1 25
0.6%
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AAPG
AAPG

Products$29.7M91%
Others$2.9M9%

HCWC
HCWC

Retail Grocery$17.1M91%
Food Service Restaurant$1.7M9%

Related Comparisons